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Changing Times
Annual Oration: Royal Victoria Hospital, Belfast, October 2001
James M Sloan
The great majority of these Orations have been
delivered by men, but since 1995 the medical
staff have to some extent redressed the balance
albeitbelatedly, andProfessor, now Dame Ingrid
AllengavetheOrationin 1995. LastearProfessor
Jennifer Adgey gave the Millennium Oration. It
gives me great pleasure to follow her as Orator
andwhen I lookdownthe listofprevious Orators
it makes me proud to join that distinguished
company. At this moment it also makes me
nervous.
Heraclitus was an ancient Greek; he was indeed
avery ancientGreek. He livedinEphesus around
500 BC but he was a man ahead ofhis time, and
he is reputed to have said "there is nothing
permanent but change". I have chosen the theme
of"Changing Times" forthis Oration and would
like to discuss some aspects of changes which
havetakenplaceinrecenttimes inthisprofession
and in my own specialty.
The first of these is the effect of recent changes
on Academic Medicine. I fear these have not
been entirely beneficial. The late Gary Love,
former Professor of Medicine in this Medical
School, gave this Oration in 1988. It was entitled
"ServingTwoMasters". Bythathemeantserving
two employers, the University and the National
Health Service. As everyone knows it is difficult
toservetwomastersandrecentlythesedifficulties
have been compounded. This is largely due to
divergencewhichhasarisenbetweenthepriorities
and objectives ofthe University and those ofthe
National Health Service. As Gary Love said, the
cardinal aspectsofacademicmedicine arepatient
care, teaching and research.
All medical staff, academic orotherwise are well
acquainted with changes in patient care. The
increasing complexity of modern medicine, the
necessity for continuous up-dating and
revalidationcoupled withincreasingexpectation
by the general public, is something which we are
all learning to live with, not only in the medical
profession but in nursing and professions allied
there-to. Similarlyteachingisnottheprerogative
of academic medicine. A great deal of
undergraduate medical teaching is carried outby
NHS staff. This hospital has a long and proud
tradition ofteaching which I will return to later.
Nonetheless with the introduction of the new
medical curriculumby the GMC three years ago,
there was a switch away from formal lectures to
problem-basedlearningandsmallgroupteaching.
Thejury remains out on the efficacy ofthis type
ofteaching butitcertainlytakes agreatdealmore
time and many more personnel to deliver. In my
own specialty, demands for teaching time
quadrupled.
Themostcontroversial aspectofrecentchangein
academic medicine has been with regard to
research and the institution of the Research
AssessmentExercise.Thisisapeer-reviewsystem
commissioned by the Higher Education Funding
Council which assesses universities on their
research performance and determines to a
considerableextenttheirfundingforthenextfive
years. Thus it has assumed very high priority in
university life. Teaching and inparticularpatient
carehavebeenforcedintothebackground. Indeed
thegreatmajorityofuniversitydepartmentshave
no responsibility for patient care. Thus it rates a
very low priority.
Assessmentis based onthree factors, the number
andqualityofpeer-reviewedpublications,number
of research support staff and, most importantly
income from research grants. The implication is
that expensive research is good research.
Consequently clinical academic staff find
themselves underunrelenting pressure to pursue
research grants and bring in income. Combining
this with a heavy clinical commitment and
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teaching is a formidable task and one which for
many is losing its appeal.
AmeetingofProfessors ofPathology throughout
the UK was held recently to discuss this matter.
It was probably a crisis meeting. The report of
this meeting' written by an eminent pathologist
andresearchworkerpullsnopunches. Itstates "it
was felt strongly that the Research Assessment
Exercise had been singularly unhelpful if not
destructive, especially in the sphere ofacademic
surgical pathology." I think the same applies to
manyspecialties wellbeyondsurgicalpathology.
The result ofthese recent policies is not difficult
to predict and is shown in Table I. These figures
have been compiled by the Council of Heads of
Medical Schools 2 and thus I think it is safe to
assume they are authentic. It shows the
considerable number of vacant posts at various
levelsinacademicmedicinethroughouttheUnited
Kingdom in October 2000 andthe numberwhich
have been vacant for more than six months. Bear
in mind that ten years ago these posts were
consideredhighlydesirable. Themostambitious,
thebrightestandthebestmedicalgraduateswould
havebeencompeting fiercely forthesepositions.
Now itappearsthey arewalking away. Ithinkthe
General Medical Council and the Higher
Education Funding Councils need to take a long
and urgent look at the consequences of their
policies in academic medicine. If the drift from
academic medicine continues, who will take
responsibility for undergraduate medical
education?
TABLE I
Summary ofVacancies in Academic Posts in
UKMedical Schools (as at 1/10/2000)
Data collected by Council of Heads of
Medical Schools
Posts Posts unfilledfor
unfilled more than 6 months
Professor 79 36
Reader/S Lecturer 145 81
Lecturer 177 98
I would now like to move on from that rather
downbeat assessment to look at some of the
changesthathavetakenplaceinmy ownspecialty
of tissue pathology in recent years. In a very
different context Harold Macmillan coined the
phrase "the winds ofchange". Sometimes itfeels
almost like a whirlwind of change. The practice
of tissue pathology or histopathology includes
autopsy practice. Morbid anatomy is the
depressing term often applied. Within the past
few months this practice has come under intense
scrutiny over the practice of tissue retention for
teaching and research and retention of small
tissue samples for microscopical examination.
What was not only accepted practice but best
practice, carried out for decades, indeed for
centuries, has now in some cases become
unacceptable in the absence of detailed consent.
This is not a suitable forum in which to discuss
this matter and I do not intend to do so. However
few people outside the department are aware of
the amount of time and energy that this
controversy has consumed and I would like to
acknowledge the enormous amount ofeffort put
inbymanymembersofthePathologydepartment
as a result of this matter. Since January of this
year the department has received over 1200
enquiries. Thesehavebeendealtwithinitially by
the secretaries within the departmentandthenby
Dr. Maureen Walsh, Dr. Meenakshi Mirakhur in
Neuropathology and in particular by Dr. Claire
Thornton. Dr .Thornton and her secretary, Mrs.
Claire Preshaw, have themselves dealt with over
1000 enquiries. These require detailed reference
to records, in some cases going back 40 or 50
years. In all instances these enquiries have been
dealt with in a patient, polite and understanding
fashion and I think this Trust owes a debt to the
people involved, particularly Dr. Thornton. The
Trusthasprovidedhelpintheformofatelephone
helpline and a great deal ofassistance in dealing
withpsychological aspects has been givenby Dr.
Nicola Rooney. No help has been provided by
Government agencies or Coroners, despite the
factthatmany oftheseautopsies werecarried out
at Coroners' request. This has been a stressful
matter on all sides.
One of the major changes in histopathology
practice over the past 30 years has been the
change in emphasis away from autopsy work to
surgical pathology, the examination of tissue
fromthelivingpatientwith aview toestablishing
the diagnosis and the extent of disease. Table II
compares the number of biopsy and operative
specimens examined inpathology laboratories in
Northern Ireland in 1970 and in the year 2000.
There has been a marked increase in this activity
over 30 years. This takes no accountofscreening
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and diagnostic cytology which have increased
almost exponentially. The number of autopsies
carried out has remained roughly the same or
fallenslightlyinthatperiod. PersonallyIwelcome
this change ofemphasis greatly. On thetechnical
side the great advance has been the advent of
immunohistochemistry (ICC)wherebyalabelled
antibody is applied to a tissue section in order to
identify cell andtissue types, geneproducts etc -
theapplications aremultitudinous. Thistechnique
wasrefinedandimprovedbyLudwigSternberger
in the 1970s. Shortly afterwards Professor Cesar
Milstein working in Cambridge described the
production of highly specific monoclonal
antibodies.3 The application of these techniques
has greatly increased and refined our diagnostic
abilities.
Table II
Surgical Pathology in N. Ireland
Specimens Reported
1970 2000
RVH 11150 23900
BCH 18050 18300
Altnagelvin 1850 11600
Antrim - 13500
Craigavon 13000
Total 31050 80300
Now for a little bit of medical science. I would
like to turn attention to some diseases in which I
have had some interest over the years and in
whichtherehasbeenremarkablechangeinrecent
times. This change has been almost exclusively
beneficial. ThediseaseIwouldprincipally liketo
discuss is Peptic Ulcer Disease.
This term covers chronic gastric and duodenal
ulcers. It is perhaps easy to forget how common
this disease was even 30-40 years ago and how
much misery, morbidity and not inconsiderable
mortalityitcaused. Itis stillquiteprevalenttoday
especially in the elderly but the treatment and
prognosis have changed completely. Surgery,
which was amainstay oftreatmentis now seldom
necessary.
Reference to a prestigious textbook of
Gastroenterology published in 1984 gives a
variety ofcauses ofchronic peptic ulcerdisease.4
Many of the listed causes were perfectly valid.
Aspirin and other non-steroidal antiflammatory
drugs are important causes of peptic ulceration
particularly gastric ulcers and this has been
increasingly recognised. Syndromes such as the
Zollinger-Ellison syndrome and multiple
endocrine neoplasia are also potent causes but
account for only a very tiny proportion ofcases;
othercauseslistedarevagueandnotveryrelevant.
Psychological stress was at that time considered
very important. This may be so but it is not the
basic underlying cause.
The first major step forward in treatment of this
disease came from the pharmaceutical industry
whenJames Black, who atthattime was working
with Smith, KlineandFrench, developedthefirst
H2 receptor antagonist drug Cimetidine or
Tagamet. He was subsequently knighted and
received a Nobel Prize for this work and
deservedly so. This was the first really effective
drug to suppress acid secretion in the stomach.
The old adage "if there is no acid there is no
ulcer" proved to be true, and in many cases
treatmentwithcimetidineallowedtheseulcers to
heal. However it was noted that once treatment
was stopped, a depressingly high percentage of
ulcers recurred and really we were no further on
in understanding why the ulcers occurred in the
first place.
Then two letters appeared in the Lancet under a
single heading,5 "Unidentified curved bacilli on
gastric epithelium in active chronic gastritis."
TheletterscamefromPerthinWesternAustralia.
The first was written by Dr. Robin Warren a
pathologist andthe secondbyDr. BarryMarshall
who was atthattime atraineegastroenterologist.
They described the presence of bacteria on the
surface of the gastric mucosa, the lining of the
stomach. Suchbacteriahadbeendescribedbefore
but had been dismissed as mere contaminants.
Marshall and Warren observed the crucial
association between the presence ofthe bacteria
andactivechronicinflammationoftheunderlying
gastric mucosa. In addition, with a lot of help
fromthethenProfessorofMicrobiologyinPerth,
StewartGoodwin,Marshallalsomanagedtogrow
the bacteria in culture. A year later Marshall and
Warren made the additional connection between
the presence ofbacteria and peptic ulcer disease
inapaperpublishedintheLancet.6Marshall isan
articulate and flamboyant man who enjoys the
limelight and is not one to hide his light under a
bushel. Warren, on the other hand appears to be
quiet and unassuming and seems happy to let
others take the glory. You will I am sure,
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Fig 1. Helicobacter pylori organisms (arrows) on the Fig 2a. Biopsy of gastric mucosa in H pylori gastritis.
surface of gastric mucosa in active chronic Thereisintenseinflammationofthelaminapropria
gastritis. Oil immersion. Giemsa. with infiltration by polymorphs, plasma cells and
lymphocytes. Hpyloriwerepresentonthemucosal
surface.
immediatelyrecognisetheseasthecharacteristics
of a typical pathologist.
There was considerable reluctance to accept
Marshall and Warren's hypothesis that peptic
ulcer disease might in most cases may be an
infectious disease. This was treated with
scepticism and in some cases with derision. It
was considered that colonies of bacteria could
not survive for any length of time in the hostile
environmentofthehumanstomachwithvery low
pH levels but they can and they do. Fig 1 shows
the surface of the mucosa and the curved or
spiral- shaped organisms which Marshall and
Warren described. Viewed under the scanning
electron microscope at a magnification of about
4000theycanbeclearly seenonthesurfaceofthe
gastric mucosa. Microbiologists rapidly
developed methods of growing the organism in
culture which is difficult. Unfortunately for the
rest of us they kept changing its name and the
bacterium became known by a series of names.
Eventually it was decided that it belonged to a
separate genus and the name of Helicobacter
pylori was adopted. This is quite sensible as it
refers to the spiral-shape ofthe organism and the
fact that it is found mainly in the pyloric antrum.
Subsequent work carried out over the next few
years showedthatthis is anexceedingly common
infection. In Western countries by the time we
reach middle-age, 50 or 60% of the population
have this infection, in the developing world the
incidence is almost 100%. What was perhaps
more relevant was the finding that in 95% of
patients with duodenal ulcer and in around 60%
of patients with gastric ulcer the infection is
present. However as I said, the hypothesis that
infection and subsequent gastritis may lead to
Fig 2b. Biopsy from the same patient 13 months after
eradication of H pylori infection. The
inflammatory infiltrate is much reduced.
Polymorphs have disappeared and only small
numbers oflymphocytes andplasmacellsremain.
chronic ulceration was difficult to prove and was
accepted only slowly. The most convincing
evidence in favour ofthis hypothesis came from
therapeutic trials. Histology helps illustrate this
with regard to gastritis (Fig 2a and 2b).
Similar work provided convincing evidence of
thebeneficialeffectoferadicationoftheinfection
onpepticulcerhealing. Suchworkwaspioneered
in Dublinby ProfessorColm O'Morain's group.7
Similar findings are summarised in a later
American study published in 1993.8 In patients
treated with acid suppression therapy and
antibiotictherapytoeradicatetheorganism,ulcers
recurred in only 2% after treatment was stopped.
In patients treated with acid suppression therapy
alone and in whom the organism was not
eradicated, ulcers recurred in 85% ofcases. That
isfairly convincing evidence andit was evidence
C The Ulster Medical Society, 2002.
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ofthistypethatfinallyconvincedeventhesceptics
that this infection is the principal cause ofpeptic
ulcer disease.
Because H. pylori inhabits the mucus layer
coveringthegastricmucosaitisnoteasilyattacked
by the body's immune system and thus in most
cases patients who contract the infection have it
fortherestoftheirlivesunless suitable treatment
is administered. It has long been known that
long-term inflammation pre-disposes to
developmentofcancerandsoonepidemiological
studies carried out in various different countries
indicated thatthere is an increased risk ofgastric
cancer in patients who have H pylori infection.
There is also an increased risk of malignant
lymphoma of the stomach although this is much
less common. Thus it became apparent that there
are two principal outcomes to long-standing
infection withHelicobacterpylori. In mostcases
(pathway 1),bacteriaandsubsequentgastritis are
confined to the antrum. The chronic active
inflammationeventuallyleadstoatrophicgastritis
and intestinal metaplasia in the antrum. This
tends to be accompanied by increased levels of
circulating serum gastrin, increased gastric acid
and increased risk ofpeptic ulcer.
In the other pathway (pathway 2), the gastritis is
more widespread and involves both the antrum
and the acid-secreting corpus ofthe stomach i.e.
a pangastritis. This gives rise to much more
diffuse atrophic gastritis further diminishing the
acid secretion and allowing the organisms to
spread. Patchy change then takes place in the
lining of the stomach whereby it comes to
resemble the lining of the small intestine
(intestinal metaplasia) and these patients are at
slightly increased risk of developing gastric
cancer.
In the past 10 or 15 years the morphological
sequence ofevents, in otherwords thechanges in
thegastric mucosawhich we can detect downthe
microscope have become fairly well defined.
Everyone in whom the infection becomes
established develops active gastritis. Most of
these patients will develop some degree of
atrophic gastritis and most will, over the years
develop intestinal metaplasia. A small minority,
especially among those in whom the disease
process follows pathway 2, will go on to develop
dysplasia which is a term for disordered growth
and asignificantproportionofthose willdevelop
carcinoma.
Thequestionarises,canweinterruptthissequence
of events before it reaches the dangerous stage.
There is considerable debate about this but I
believe that in the early stages this sequence can
be stopped and perhaps reversed. Dr. Catherine
Larkin carried out a study on the effect of
eradication ofHelicobacter on atrophic gastritis
affectingthebody ofthe stomach.9 Shemeasured
gastric acid levels and serum gastrin levels and
found that in most cases these revert to normal
aftertheorganismiseliminated. Thesearemarkers
of atrophic gastritis and their return to normal
levels indicates reversal or at least lack of
progression of this process. Histology supports
this. Biopsies taken at the start of the study
showedpatchymildormoderateatrophicgastritis
of the mucosa of the corpus of the stomach in
most patients with H Pylori infection. Biopsies
taken approx one year after eradication of the
infection showed not only improvement of the
activegastritisbutinmostcasespartialregression
of the atrophic gastritis. However none of the
cases studied showed intestinal metaplasia on
biopsy and it is likely that a point of no return is
reached. Onceintestinalmetaplasiaisestablished,
it is doubtful ifthe mucosa will revert to normal.
The incidence of gastric cancer has been falling
throughout the world quite dramatically which
can only be good news. However there is a sting
in the tail - there is always a sting in the tail. The
sting is associated with Barrett's oesophagus. In
this condition the normal lining of the lower
oesophagus is replaced by patches or tongues of
gastric mucosa which have moved upwards in a
cephalicdirection. Itisthoughttobeduetoreflux
ofacid contents in the stomach upwards into the
oesophagus. In these circumstances the normal
lining of the lower oesophagus changes to
resemble that of the stomach. Barrett's
oesophagus is usually fairly harmless. It causes
heartburnand sometimesulcerationbutin asmall
numberofcases itprogresses to adenocarcinoma
ofthe lower oesophagus or thejunction between
the oesophagus and stomach as shown here. This
tumour is highly aggressive and while incidence
ofcancerofthe more distal stomachhas declined
considerably the sting in the tail is that
adenocarcinoma of the lower oesophagus and
upper end ofthe stomach has increasedrecently.
Thiswasfirstnotedintheearly 1980sandreported
in 1991 and the trend has continued.
I had the pleasure ofworking with Dr. Catherine
Gleeson when she did her PhD under the
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supervision of Dr. Hilary Russell. In her PhD
Kate studied the molecular biology of Barrett's
oesophagus and related adenocarcinoma. She
published a series of good quality papers and
among other things identified chromosomal loci
whichmaybeinvolvedinprogressionofBarrett's
epithelium to cancer.11 In addition her molecular
studies supported the theory that there is a step-
wise sequence leading from relatively normal
mucosa to malignancy similar to that already
described in the stomach.12 This progression
consists of replacement of the squamous
epithelium ofthe lower oesophagus by columnar
epithelium i.e. Barrett's oesophagus. The next
step is development of intestinal metaplasia in
Barrett's mucosa. In a tiny proportion of such
cases Dr. Gleeson detected molecular changes at
this stage similar to those in fully fledged cancer
despitethefactthatthere wasnothingalarming in
the histology. In a small proportion of cases
intestinal metaplasiaproceeds to dysplasiaandin
a further minority to invasive adenocarcinoma.
I should state, in case I sound alarmist, that the
risk of developing adenocarcinoma in Barrett's
oesophagus isquitelow. Earlierstudies indicated
that the risk was increased by approximately 40-
150 times but Dr. Liam Murray has compiled a
sizeable series of local cases which have been
followed up for a considerable number of years.
His findings indicate that the risk of cancer
associated with Barrett's oesophagus is
approximately fifteen times that ofthe rest ofthe
population and considerably less than earlier
estimates."3
The challenge in the future will be to identify the
relatively small number of patients who are at
riskofdevelopingcancerwellbeforetheyactually
do so. At present histological detection of
dysplasia remains the basis for this but histology
in its present form is a fairly blunt instrument.
Hopefully improved molecular biology
techniques such as those used by Dr. Gleeson or
perhaps computer assisted image analysis of
biopsymaterialwillidentifypotentiallydangerous
abnormalities within cells with greaterprecision
than we have at present and will thus be able to
identify patients at risk at an earlier stage long
before cancer develops. That remains the goal
with this particular cancer and indeed with most
cancers.
Finally I would like to turn to the changes taking
place on this site. They are quite momentous and
are there for all to see. We are moving from the
familiar but rather tired facade fronting onto the
Grosvenor Road to a new building. More
importantly we are moving from wards which
have barely changed since the Edwardian era.
Phase I ofthe new building is now complete and
we have a pristine brand new hospital which will
hopefully provide much needed improvement in
facilities for patients, relatives and staff alike. I
do hope that we can keep it in that pristine state
ofcleanliness. Unfortunately on this site, parts of
theestateare in averyrun-downcondition. There
is anabundance oflitter, adearthoflitterbins and
in some places fixtures and fittings are in a
dilapidated state. Litter and vandalism are sadly
endemic in this country and 20 years of under-
fundingonthis sitemeanthatthere islittlemoney
left over for site maintenance after provision of
clinical services. Hopefully with the opening of
the new hospital things will changeforthebetter.
Itis ofcourse very easytoblame managementfor
everything. We all have our pet gripes. In
Laboratory Medicine for instance, Haematology
has been moved off this site and we find it
difficult to understand how a hospital such as
this, containing a majortrauma centre, obstetrics
and substantial cancer services can function
optimally without the presence of Consultant
Haematologists on site. It is however worth
remembering that in the early 1990s there was a
realdangerthattheRoyalVictoriaHospitalwould
be downgraded and that acute hospital services
would be moved offthis site. Instead it remains a
centre point ofhospital services and referrals for
the Province and we have the first phase of the
newhospital. To achievethis U-turn hasrequired
determination, intensive lobbying and
involvement inpolitics atthehighestlevelby our
management team. Few of us are aware of the
amountofeffortinvolvedparticularly on thepart
ofthe past and presentChairmen ofthe Trust and
our Chief Executive Mr. William McKee. The
cost of phase I of the new hospital has been 47
millionpounds. The completion was supposed to
takeplacein 36 months. Infactittook30 months.
The builders also deserve great credit for
completing ahead of schedule and for causing
much less disruption to the everyday running of
the hospital than many ofus anticipated. Phase II
will cost 67 million pounds.
The purpose of the Oration is not to give the
Orator a chance to indulge himself. The purpose
is to welcome new students to this hospital and I
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bid you a very warm welcome. I have spoken
briefly about the long and proud tradition of
teaching in this hospital and I have no doubt it
contributes to the high reputation of Queen's
Medical School as a teaching centre. All aspects
of professional life are now subject to scrutiny
and assessment. Teaching is no exception. In the
last Teaching Quality Assessment this Medical
School was rated highly. In soccer parlance it is
well in the top half of the Premiership division.
The Dental School did even better, indeed it
could not have done any better. It won the
equivalent of the league and cup double. Such
standards will be hard to maintain but as this
hospital is in the forefront of teaching I am
confident we can offer you a good medical and
dental education. I wish you well in yourcareers.
It will be demanding but hopefully rewarding.
Thecare andwelfare ofyourpatients willbeyour
first priority. I wish you well with your patients
and also with the colleagues you will be working
with.
There are a number of people I have to
acknowledge with regard to this Oration. First,
foremostandmostimportantly arethecolleagues
I have worked with for many years in the
Pathology Department on this site. Very few
people are as lucky as I have been in this respect
withregardto colleagues at all grades and levels.
To these colleagues I am exceedingly grateful.
Mostofthemhave ahealthy senseofhumourand
Iwouldrecommendthisasanessentialingredient
for harmonious relations.
I wouldlike to acknowledge the late Mr. Terence
Kennedy and the late Mr. John Gibbons. They
were both expert surgeons. Terence Kennedy
specialised in surgery ofthe stomach and treated
many cases ofpeptic ulcer and gastric cancer. In
addition he was a skilled endocrine surgeon and
togetherwithKeithBuchananandTeddyMcllrath
raised treatment of neuroendocrine tumours in
thisProvincetoworld-class levels. JohnGibbons
was a highly skilled thoracic surgeon and a
marvellouslyfriendlyand sociableperson. These
men had very different personalities but had
much in common. They were excellent surgeons
with a busy workload. Not only did they have to
treateveryday disease butfor many years like all
their surgical colleagues they had to treat
horrendous trauma caused by terrorist activity.
Lesser men might have wilted but they did the
veryopposite. Theypossessedsharpandenquiring
minds and had the ability to see beyond the
everydayroutine. They were constantly sparking
off ideas and research projects for younger
colleagues. Many of us benefited greatly from
knowing them.
There are several colleagues outside pathology,
too numerous to mention individually in this
article whom I gratefully acknowledge. They
include gastroenterologists, endocrinologists,
surgeons, radiologists, epidemiologists,
molecular biologists and computer experts. A
few have retired, others are at the peak of their
careers and some are starting out. It has been a
pleasure and an education to work with them.
They have all contributed greatly to the work of
this hospital and ifwe can continue to recruit and
retain people ofthis calibre -and we will have to
work at it - then the future of this hospital is
assured.
While on the subject ofchange one final piece of
mildblackhumour-"Ifyouareinabadsituation,
don't worry, it'll change. If you are in a good
situation, don't worry, it'll change".'4
James M. Sloan
Date: 4October2001.
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